DUBLIN, September 28, 2021 / PRNewswire / – The report “Emerging Materials Influence Global Vaccine Packaging: 2021 Technology Opportunity Analysis” has been added to ResearchAndMarkets.com offer.
The materials used for packaging pharmaceutical vaccines vary and many are well established in the vaccine transport and storage market. Despite the great variety, some of the most widely used vaccine packaging materials still experience glass delamination, instability, and pH alteration over time.
The global COVID-19 pandemic has amplified the need not only for targeted vaccines, but also for effective packaging materials that can help maintain their effectiveness. With the adoption of various vaccine formulations, personalized storage conditions during product transport are mandatory.
To distribute COVID-19 (and other) vaccines around the world without damage or incidence of cross-contamination, packaging products such as bags, vials, ampoules, special freezers, containers and many more are used. The manufacture of these products requires high strength and performance materials that will outperform conventional materials, which are often unable to meet vaccine handling standards.
For example, traditional borosilicate glass is prone to breakage and often has delamination issues, which impacts the effectiveness of the drug. To address these issues, manufacturers are investigating alternative materials such as aluminosilicate glass, which minimizes particulate contamination and crack formation.
To meet the global demand for ultra-cold chain requirements needed for the storage and transport of COVID-19 vaccines, innovations such as phase change materials and smart materials are being tested for the manufacture of freezers and qualified containers. Additionally, the use of smart packaging can help ensure supply chain transparency with increased security.
Sustainability is a major trend that is also influencing the field of vaccine packaging. To minimize packaging waste and its negative impact on the environment, manufacturers are looking for compostable and biodegradable secondary packaging options, such as shipping coolers derived from plant sources or recyclable content. Overall, stakeholders in the vaccine packaging value chain are using various strategies to develop primary, secondary and tertiary packaging materials that will ensure the efficacy and efficacy of vaccines and other pharmaceutical excipients.
This research on the global vaccine packaging market will answer the following questions:
- What emerging materials are gaining in importance for vaccine packaging?
- What are the driving forces behind research efforts and innovations in vaccine packaging materials?
- What are the main activities of stakeholders that are targeted towards adoption of emerging materials?
- What are the growth opportunities for emerging materials in vaccine packaging?
Main topics covered:
1 Strategic Imperatives
1.1 Why is it more and more difficult to develop?
1.2 The strategic imperative
1.3 The impact of the three main strategic imperatives on vaccine packaging materials
1.4 About the Growth Pipeline Engine
1.5 Growth Opportunities Fuel the Growth Pipeline Engine
1.6 Research methodology
2 Growth environment
2.1 Research context
2.2 Scope of the research: key research questions Will respond
2.3 The need for better vaccine packaging materials
2.4 Industrial needs influencing research efforts on vaccine packaging materials
2.5 The different materials sought to replace traditional packaging materials
2.6 Smart packaging opportunities in the COVID-19 vaccine supply chain
3 Vaccine packaging: key trends and requirements
3.1 Vaccine packaging needs and requirements
3.2 COVID-19 vaccine packaging requirements and efforts to overcome challenges
3.3 Trends impacting R&D in vaccine packaging by North America (NA) and Europe
3.4 Trends affecting R&D in vaccine packaging in Asia Pacific (APAC) and Middle East
3.5 Factors Influencing Material Selection and Adoption
3.6 Current trends influencing the R&D and adoption of vaccine packaging materials
3.7 Emerging trends influencing the adoption of vaccine packaging materials
4 Emerging materials for vaccine packaging: technology analysis
4.1 The different materials explored for use in vaccine packaging
4.2 Recycled materials and polymers tested for use in secondary packaging
4.3 Aluminosilicate glass for the manufacture of vials is gaining in importance due to its high mechanical strength
4.4 Growing demand for transparent polymers allowing the use of COCs for vaccine packaging
4.5 High purity quartz vials as a potential alternative to type 1 borosilicate glass vials
4.6 Hybrid vials made from polymers and glass nanocoatings provide effective barrier properties
4.7 Bio-derived EPS for secondary and tertiary packaging improves the environmental profile
4.8 Fluoropolymers may offer improved stability and shelf life compared to glass vials
4.9 Thin films of cellulosic matrix stabilized by a surfactant under research for the storage of vaccines and biological products
4.10 CFMs considered for packaging vaccines due to their high latent heat properties
4.11 Folding flat cardboard coated with renewable fibers used for vaccine vials and injectors
4.12 Carbon neutral and recyclable biopolymers of interest to the pharmaceutical industry
4.13 Post-consumer recycled PET as secondary packaging material for vaccines
5 IP landscape
5.1 Companies in United States Main property of patents in vaccine packaging
5.2 The analysis of intellectual property shows a strong patent filing activity in United States
5.3 Classification of materials and key themes of innovation in the context of intellectual property analysis
6 industry initiatives
6.1 Acquisitions and partnerships intended to extend the geographical presence and meet industrial needs
6.2 Expansion of production capacity mainly focused on primary pharmaceutical packaging applications
6.3 Product launches mainly focused on vaccine storage and packaging materials
6.4 Researchers exploring the use of nanocoated PS glass vials for RNA-based vaccines
6.5 Public and private funding projects aimed at developing alternative materials
7 companies to act
7.1 Hybrid plastic-glass vials for the storage of COVID-19 vaccines and therapeutic products
7.2 The ULT shipper guarantees high thermal stability for temperature sensitive mRNA vaccines
7.3 The formulation of aluminosilicate glass eliminates the risk of delamination and resists cracking
7.4 Surfactant stabilized cellulosic matrix materials can store vaccines at ambient and elevated temperatures
7.5 Fluoropolymer foam ensures safe transport of vaccines requiring ultra-cold chain support
7.6 Shipping packaging container with PCM designed for all weather conditions
7.7 Bio-based PCMs offer better thermal performance than paraffin-based materials
7.8 Recyclable and compostable vaccine shipping cooler made from plant-based raw materials
7.9 The biodegradable sugar-based polymer, a promising alternative to petroleum-based secondary packaging
7.10 Metal-free syringes for the packaging of active ingredients derived from biotechnology
7.11 Polymer Packaging Solution Protects COVID-19 Rapid Test Kits from Moisture and Oxygen
8 growth opportunities
8.1 Growth opportunity 1: Development of conventional alternatives to borosilicate for the primary packaging of vaccines
8.2 Growth opportunity 2: Development of biodegradable and compostable shipping coolers for secondary packaging
8.3 Growth opportunity 3: Ultra-low freezing temperature requirement for COVID-19 vaccines reshaping the global vaccine cold chain
For more information on this report, visit https://www.researchandmarkets.com/r/jqfgi5
Research and markets
Laura Wood, senior
For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716
SOURCE Research and Markets